CLNN P/E Ratio
P/E Ratio as of Jul 1, 2025: -1.36
Average-1.45
Median-1.43
Minimum-1.70
Maximum-1.31
-1.36
Past Month+0.34 (20.00%)
The P/E ratio for CLNN is -1.36 as of Jul 1, 2025. This represents a decrease of -89.86% compared to its 12-month average P/E ratio of -13.41. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Clene Nanomedicine P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Clene Nanomedicine’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Clene Nanomedicine to industry peers.
Clene Nanomedicine P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Clene Nanomedicine’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Clene Nanomedicine to industry peers.
CLNN P/E Ratio Insights
See Clene Nanomedicine’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CLNN
Order type
Buy in
Order amount
Est. shares
0 shares
CLNN P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $3.90 | -1.36 |
| Jun 2, 2025 | $4.90 | -1.70 |
| May 1, 2025 | $3.00 | -1.60 |
| Apr 1, 2025 | $2.58 | -1.38 |
| Mar 3, 2025 | $4.33 | -15.51 |
| Feb 3, 2025 | $4.57 | -16.37 |
| Jan 2, 2025 | $5.39 | -19.31 |
CLNN End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.36 | -92.85% |
| 2024 | -19.02 | +2,967.74% |
| 2023 | -0.62 | -76.06% |
| 2022 | -2.59 | -85.74% |
| 2021 | -18.16 | +77.17% |
| 2020 | -10.25 | — |
FAQs About Clene Nanomedicine (CLNN) P/E ratio
The latest P/E ratio of CLNN is -1.36, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Clene Nanomedicine’s last 12-month average P/E ratio is -13.41, compared to its current P/E ratio of -1.36. This reflects a decrease of -89.86%.
Clene Nanomedicine’s current P/E ratio of -1.36 is lower than its last 12-month average P/E of -13.41. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Clene Nanomedicine’s average P/E ratio over the last 3 years is -4.67. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Clene Nanomedicine’s average P/E ratio over the last 5 years is -5.96. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.